Square Pharmaceuticals Kenya EPZ Ltd, a subsidiary of Square Pharmaceuticals Ltd (SPL), Bangladesh, on Monday January 8th 2018 started construction of its manufacturing plant in Nairobi through a groundbreaking ceremony.
Adan Mohamed, Kenya’s cabinet secretary for the ministry of industry, trade and cooperatives; Maj Gen Abul Kalam Mohammad Humayun Kabir, high commissioner of Bangladesh to Kenya, and Tapan Chowdhury, managing director of Square Pharmaceuticals, attended the ceremony.
The state-of-the-art plant is a benchmark for the Bangladeshi industry’s achievements as SPL would be the first to build its own plant abroad. SPL started exporting to Kenya in 2005 and registered 117 products with the Pharmacy and Poison Board, Kenya’s drug regulatory agency. SPL has been running for the last 60 years with manufacturing knowledge of all possible dosages, exporting products to 42 countries including Asia, Africa, Europe and America, the statement added.
Zuri Events provided the following services: conference management, media management, event production management and catering.
Square Pharmaceuticals Kenya EPZ aimed to fulfil the unmet demands of medicine in Kenya, Tanzania, Rwanda, Burundi, Uganda and South Sudan.
Kenya was identified as the region’s most preferred place for business.
The plant will be capable of manufacturing two billion tablets and capsules and 60 million bottles of liquid formulations.